<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
69336-349-90
</NDCCode>
<PackageDescription>
90 CAPSULE in 1 BOTTLE (69336-349-90)
</PackageDescription>
<NDC11Code>
69336-0349-90
</NDC11Code>
<ProductNDC>
69336-349
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Luvira
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Luvira
</NonProprietaryName>
<DosageFormName>
CAPSULE
</DosageFormName>
<RouteName>
ORAL
</RouteName>
<StartMarketingDate>
20200117
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
UNAPPROVED DRUG OTHER
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Sterling-Knight Pharmaceuticals, LLC
</LabelerName>
<SubstanceName>
OMEGA-3 FATTY ACIDS; 12-HYDROXYEICOSAPENTAENOIC ACID, (12R)-; 4,7,10,13,16,19-DOCOSAHEXAENOIC ACID, (4E,7E,10E,13E,16E,19E)-
</SubstanceName>
<StrengthNumber>
1220; 465; 375
</StrengthNumber>
<StrengthUnit>
mg/1; mg/1; mg/1
</StrengthUnit>
<Pharm_Classes>
Fatty Acids, Omega-3 [CS],Omega-3 Fatty Acid [EPC]
</Pharm_Classes>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2022-01-04
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20211231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20200117
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>